Category RESEARCH

VectorBuilder

VectorBuilder Launches High-Stability MuteFree™ AAV to Enhance Gene Therapy Manufacturing Reliability

VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene therapy…

Read MoreVectorBuilder Launches High-Stability MuteFree™ AAV to Enhance Gene Therapy Manufacturing Reliability
Thermo Fisher

Thermo Fisher Scientific’s PPD Clinical Research Unit Partners with HealthVerity to Enhance Real-World Data Capabilities

Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance…

Read MoreThermo Fisher Scientific’s PPD Clinical Research Unit Partners with HealthVerity to Enhance Real-World Data Capabilities
Nordic Cold

Nordic Cold Chain Solutions launches GLP-1 and small-format packaging innovation lab.

Nordic Cold Chain Solutions Launches GLP-1 & Small-Format Packaging Innovation Lab Nordic Cold Chain Solutions today announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab, a customer-first initiative designed to help specialty pharmacies, pharmaceutical manufacturers, and e-commerce leaders…

Read MoreNordic Cold Chain Solutions launches GLP-1 and small-format packaging innovation lab.
NImmune

NImmune to present LANCL2 therapeutic data at IMMUNOLOGY2026.

NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026 NImmune Biopharma a private late-stage precision inflammation and immunology (“I&I”) biopharmaceutical company, will present first-ever preclinical and translational data demonstrating the…

Read MoreNImmune to present LANCL2 therapeutic data at IMMUNOLOGY2026.
PhaseWell

PhaseWell Research acquires Chase Medical Research to expand clinical trial capabilities in Connecticut.

PhaseWell Research Acquires Chase Medical Research to Expand Clinical Trial Capabilities in Connecticut PhaseWell Research a multisite clinical research company, today announced the strategic acquisition of Chase Medical Research (“CMR”). Under the leadership of founder, key opinion leader, and lead…

Read MorePhaseWell Research acquires Chase Medical Research to expand clinical trial capabilities in Connecticut.

Veristat Boosts EU Regulatory & Clinical Support for Chinese Pharma and Device Firms

Veristat Expands Regulatory and Clinical Trial Support for Chinese Pharmaceutical and Medical Device Companies Entering Global Markets Veristat, a global contract research organization (CRO) and consulting firm known for its expertise in complex clinical trials, has announced the expansion of…

Read MoreVeristat Boosts EU Regulatory & Clinical Support for Chinese Pharma and Device Firms

Argonne Studies Pollutant-Destroying Molecules for Water Treatment

Researchers at Argonne National Laboratory analyze reactive molecules generated during electrocatalysis to better understand how electricity-driven processes can break down persistent water pollutants Modern society relies on thousands of synthetic chemicals that improve everyday life, from vibrant textile dyes to…

Read MoreArgonne Studies Pollutant-Destroying Molecules for Water Treatment

LabVantage lanza CORTEX: LIMS potenciado por IA para laboratorios

LabVantage Solutions has introduced a new artificial intelligence–driven platform designed to transform how laboratories manage data, workflows, and automation. The company announced the launch of LabVantage CORTEX, a next-generation platform that combines artificial intelligence (AI), advanced analytics, and automation technologies…

Read MoreLabVantage lanza CORTEX: LIMS potenciado por IA para laboratorios

BioMed Realty & CordenPharma Expand Peptide Lab at LEED Gold Facility in Boulder

BioMed Realty and CordenPharma Colorado Expand Peptide Development Capacity with New Facility in Boulder BioMed Realty, a leading private owner and operator of real estate dedicated to the life sciences, technology, and innovation sectors, has announced a major new partnership…

Read MoreBioMed Realty & CordenPharma Expand Peptide Lab at LEED Gold Facility in Boulder

NEJM Publishes First Evidence of Disease Modification in Dravet Syndrome

New Study in NEJM Highlights Potential Disease-Modifying Treatment for Dravet Syndrome Biotechnology company Stoke Therapeutics and global neuroscience firm Biogen have announced the publication of important new research on the investigational medicine zorevunersen in the prestigious medical journal The New…

Read MoreNEJM Publishes First Evidence of Disease Modification in Dravet Syndrome